Benchtop flow cytometry cell analyzer for immunology, allergy, and cell-based assay research
Denmark · Kgs. Lyngby · how to bid here →
Your path to submission
- Deadline: 23 October at 08:00 — 19 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: ENG.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (68 awards, most recently September 2026) — the next award is due around October 2026 by that rhythm. The last award went to VWR International A/S.n = 68
- 6% of this buyer's awards went to companies that had already won here before (274 awards since 2018, spread over 120 companies). That is well below the sector norm (19%) — this buyer switches suppliers more often than others.n = 274 awards since 2018
- 73% of the bids received came from small and medium-sized enterprises (6 procedures with a bid mix). Sector: 25%.n = 6
- 0% of the bids received came from other countries (6 procedures with a bid mix) — all bidders, not just the winners. Sector: 18%.n = 6
- The median procedure drew just one bid (245 procedures with a bid count); 52% ended with a single bidder. Sector: median 1 bids.n = 245
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 29/09/2026.
Foreign bidders
In Denmark · Laboratory & optical equipment, 172 contracts went to foreign companies over the last 3 years (of 389 recorded awards) — mostly from Germany, Finland, Sweden.
Submission language: ENG.
Typical field: median 1 (from 64 awards).
What the buyer is looking for
This tender concerns DTU's planned procurement of a benchtop flow cytometer. The purpose of the planned acquisition is to acquire a benchtop research-use flow cytometry cell analyzer suitable for multicolour immunophenotyping, basophil activation testing, rare-event analysis, plate-based acquisition, and future development of complex immune-cell assays. The instrument must support robust analysis of human and animal research samples, including low-frequency immune-cell populations and activation-marker readouts.
What you must prove — eligibility criteria
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Waters A/S | 4 | 2024–2025 |
| Samco Inc | 2 | 2025 |
| AH Diagnostics | 2 | 2025 |
| Parcitank SA | 2 | 2025–2026 |
| Bruker Nordic AB | 2 | 2025 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.